Global Drugs For Erectile Dysfunction Market Forecast To 2023

The global drugs for erectile dysfunction market is expected to decline from $5 billion in 2019 to $3.4 billion in 2020 at a compound annual growth rate (CAGR) of -32.5%. The decline is mainly due to the disruption caused by the lockdown measure across various countries to contain COVID-19 spread. Currently there is a low demand for genito-urinary drugs mainly as people are staying at home and are less likely to get exposed to factors that might cause genito-urinary infections, or other hormonal diseases caused by lifestyle changes or eating habits. The market is then expected to recover and grow at a CAGR of 3.7% from 2021 and reach $5.7 billion in 2023. Drastic increase in the number of chronic diseases drives the erectile dysfunction drugs market. Erectile dysfunction is mainly caused by diseases resulting from sedentary lifestyles such as cardiovascular diseases, diabetes, obesity, and high blood pressure. However, patients suffering from erectile dysfunction do not seek treatment owing to factors such as lack of education, lack of awareness, strong religious beliefs, social taboo, and low socioeconomic status. These factors are responsible for the patients suffering from erectile dysfunction to reject or avoid the treatment.

The erectile dysfunction (ED) drugs market consists of sales of ED drugs and related services. Erectile dysfunction is the inability to achieve or keep up penile erection in men.

Request For A Sample For The Global Drugs For Erectile Dysfunction Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2443&type=smp

The global drugs for erectile dysfunction market is further segmented based on type and geography.
By Drugs: Sildenafil Citrate, Mirodenafil, Vardenafil
By End users: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Mode of Administration: Oral, Topical, Injections.
By Geography: The global drugs for erectile dysfunction market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, the North American drugs for erectile dysfunction market accounts for the largest share in the global drugs for erectile dysfunction market.

Read More On The Report For The Global Drugs For Erectile Dysfunction Market At:
https://www.thebusinessresearchcompany.com/report/drugs-for-erectile-dysfunction-global-market-report

Trends In The Drugs For Erectile Dysfunction Market
New drug delivery techniques such as the use of pellets and creams are being implemented by many companies in the erectile dysfunction drugs market. Pellets and creams will have more efficacy and performance in ED and these are also more effective and safer to use. These benefits from drug delivery techniques will increase the scope of the erectile dysfunction drugs market.
Drugs For Erectile Dysfunction Global Market Report 2020 is one of a series of new reports from The Business Research Company that provides drugs for erectile dysfunction market overviews, analyzes and forecasts drugs for erectile dysfunction market size and growth for the global drugs for erectile dysfunction market, drugs for erectile dysfunction market share, drugs for erectile dysfunction market players, drugs for erectile dysfunction market size, drugs for erectile dysfunction market segments and geographies, drugs for erectile dysfunction market trends, drugs for erectile dysfunction market drivers and drugs for erectile dysfunction market restraints, drugs for erectile dysfunction market’s leading competitors’ revenues, profiles and market shares. The drugs for erectile dysfunction market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.